189 related articles for article (PubMed ID: 9175029)
1. Successful treatment of early secondary myelofibrosis in SLE with IVIG.
Aharon A; Levy Y; Bar-Dayan Y; Afek A; Zandman-Goddard G; Skurnik Y; Fabrrizzi F; Shoenfeld Y
Lupus; 1997; 6(4):408-11. PubMed ID: 9175029
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune myelofibrosis associated with systemic lupus erythematosus: a case report.
Wibowo T; Kawada S; Ishida Y; Yoshimine Y; Ishikawa N; Kawamoto K; Kato Y; Higa S; Ogata A; Maeda K
Mod Rheumatol Case Rep; 2020 Jan; 4(1):28-33. PubMed ID: 33086960
[TBL] [Abstract][Full Text] [Related]
3. Systemic lupus erythematosus presenting as myelofibrosis.
Konstantopoulos K; Terpos E; Prinolakis H; Kanta A; Variami E; Kanellopoulou G; Vaiopoulos G; Floros A; Androulaki A; Meletis J
Haematologia (Budap); 1998; 29(2):153-6. PubMed ID: 9728808
[TBL] [Abstract][Full Text] [Related]
4. Systemic lupus erythematosus presenting with myelofibrosis.
Foley-Nolan D; Martin MF; Rowbotham D; McVerry A; Gooi HC
J Rheumatol; 1992 Aug; 19(8):1303-4. PubMed ID: 1404171
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune myelofibrosis. A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus.
Paquette RL; Meshkinpour A; Rosen PJ
Medicine (Baltimore); 1994 May; 73(3):145-52. PubMed ID: 8190037
[TBL] [Abstract][Full Text] [Related]
6. [Pancytopenia secondary to autoimmune myelofibrosis revealing a male case of systemic lupus].
Driouach S; Mounir A; Elkhader S; Zinebi A; Moudden MK
Ann Biol Clin (Paris); 2019 Jun; 77(3):327-330. PubMed ID: 31219422
[TBL] [Abstract][Full Text] [Related]
7. Myelofibrosis in systemic lupus erythematosus.
Kiss E; Gál I; Simkovics E; Kiss A; Bányai A; Szakáll S; Szegedi G
Leuk Lymphoma; 2000 Nov; 39(5-6):661-5. PubMed ID: 11342352
[TBL] [Abstract][Full Text] [Related]
8. Myelofibrosis and systemic lupus erythematosus: reversal of fibrosis with high-dose corticosteroid therapy.
Inoue Y; Matsubara A; Okuya S; Okafuji K; Kaku K; Kaneko T
Acta Haematol; 1992; 88(1):32-6. PubMed ID: 1414159
[TBL] [Abstract][Full Text] [Related]
9. Reversible myelofibrosis secondary to systemic lupus erythematosus.
Rama Krishna Reddy MM; Boloor A; Thomas NK
BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37591626
[TBL] [Abstract][Full Text] [Related]
10. Systemic lupus erythematosus and myelofibrosis.
Kaelin WG; Spivak JL
Am J Med; 1986 Nov; 81(5):935-8. PubMed ID: 3777001
[TBL] [Abstract][Full Text] [Related]
11. Myelofibrosis as a cause of pancytopenia in systemic lupus erythematosus.
Daly HM; Scott GL
J Clin Pathol; 1983 Nov; 36(11):1219-22. PubMed ID: 6630572
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune myelofibrosis and systemic lupus erythematosus in a middle-aged male presenting only with severe anemia: a case report.
Pundole X; Konoplev S; Oo TH; Lu H
Medicine (Baltimore); 2015 May; 94(19):e741. PubMed ID: 25984660
[TBL] [Abstract][Full Text] [Related]
13. Neutropenia associated with myelofibrosis in systemic lupus erythematosus.
Borba EF; Pereira RM; Velloso ED; Pereira IA; Goncalves CR; Yoshinari NH
Acta Haematol; 1993; 89(2):82-5. PubMed ID: 8503249
[TBL] [Abstract][Full Text] [Related]
14. [A case of elderly-onset systemic lupus erythematosus (SLE) complicated with severe liver dysfunction and pancytopenia due to myelofibrosis].
Kageyama Y
Nihon Ronen Igakkai Zasshi; 1999 Dec; 36(12):881-6. PubMed ID: 10689900
[TBL] [Abstract][Full Text] [Related]
15. [A case of systemic lupus erythematosus presenting with myelofibrosis as a cause of pancytopenia].
Fukuya H; Hirose W; Masuda T; Kawai T; Watanabe K; Kawagoe M
Ryumachi; 1994 Aug; 34(4):773-8. PubMed ID: 7974029
[TBL] [Abstract][Full Text] [Related]
16. Febrile episode unmasking neuropsychiatric systemic lupus erythematosus with lytic lesions caused by secondary autoimmune myelofibrosis: Case report.
Bratu IF; Ribigan AC; Mihailă-Bâldea S; Badea R; Stefan D; Davidoiu C; Casaru B; Antochi F
Medicine (Baltimore); 2021 Dec; 100(51):e28251. PubMed ID: 34941099
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune myelofibrosis with pancytopenia as a presenting manifestation of systemic lupus erythematosus responsive to mycophenolate mofetil.
Ungprasert P; Chowdhary VR; Davis MD; Makol A
Lupus; 2016 Apr; 25(4):427-30. PubMed ID: 26537421
[TBL] [Abstract][Full Text] [Related]
18. Gelatinous transformation of the bone marrow in systemic lupus erythematosus.
Yamamoto M; Belmont HM; Utsunomiya M; Hidaka Y; Kishimoto M
Lupus; 2009 Oct; 18(12):1108-11. PubMed ID: 19762388
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow as a target organ of systemic lupus erythematosus: analysis of cases with myelofibrosis.
Üsküdar Cansu D; Üsküdar Teke H; Işiksoy S; Korkmaz C
Int J Rheum Dis; 2018 May; 21(5):1049-1059. PubMed ID: 29671953
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin therapy and systemic lupus erythematosus.
Zandman-Goddard G; Levy Y; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):219-28. PubMed ID: 16391397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
